These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29965759)

  • 1. 2,4-Diaminoquinazolines as Dual Toll-like Receptor (TLR) 7/8 Modulators for the Treatment of Hepatitis B Virus.
    Embrechts W; Herschke F; Pauwels F; Stoops B; Last S; Pieters S; Pande V; Pille G; Amssoms K; Smyej I; Dhuyvetter D; Scholliers A; Mostmans W; Van Dijck K; Van Schoubroeck B; Thone T; De Pooter D; Fanning G; Jonckers THM; Horton H; Raboisson P; McGowan D
    J Med Chem; 2018 Jul; 61(14):6236-6246. PubMed ID: 29965759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Pyrimidine Toll-like Receptor 7 and 8 Dual Agonists to Treat Hepatitis B Virus.
    McGowan D; Herschke F; Pauwels F; Stoops B; Last S; Pieters S; Scholliers A; Thoné T; Van Schoubroeck B; De Pooter D; Mostmans W; Khamlichi MD; Embrechts W; Dhuyvetter D; Smyej I; Arnoult E; Demin S; Borghys H; Fanning G; Vlach J; Raboisson P
    J Med Chem; 2016 Sep; 59(17):7936-49. PubMed ID: 27513093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of selective 2,4-diaminoquinazoline toll-like receptor 7 (TLR 7) agonists.
    Pieters S; McGowan D; Herschke F; Pauwels F; Stoops B; Last S; Embrechts W; Scholliers A; Mostmans W; Van Dijck K; Van Schoubroeck B; Thoné T; De Pooter D; Fanning G; Rosauro ML; Khamlichi MD; Houpis I; Arnoult E; Jonckers THM; Raboisson P
    Bioorg Med Chem Lett; 2018 Feb; 28(4):711-719. PubMed ID: 29366653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B.
    Mackman RL; Mish M; Chin G; Perry JK; Appleby T; Aktoudianakis V; Metobo S; Pyun P; Niu C; Daffis S; Yu H; Zheng J; Villasenor AG; Zablocki J; Chamberlain J; Jin H; Lee G; Suekawa-Pirrone K; Santos R; Delaney WE; Fletcher SP
    J Med Chem; 2020 Sep; 63(18):10188-10203. PubMed ID: 32407112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
    Vlach J; Bender AT; Przetak M; Pereira A; Deshpande A; Johnson TL; Reissig S; Tzvetkov E; Musil D; Morse NT; Haselmayer P; Zimmerli SC; Okitsu SL; Walsky RL; Sherer B
    J Pharmacol Exp Ther; 2021 Mar; 376(3):397-409. PubMed ID: 33328334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B.
    McGowan DC; Herschke F; Pauwels F; Stoops B; Smyej I; Last S; Pieters S; Embrechts W; Khamlichi MD; Thoné T; Van Schoubroeck B; Mostmans W; Wuyts D; Verstappen D; Scholliers A; De Pooter D; Dhuyvetter D; Borghys H; Tuefferd M; Arnoult E; Hong J; Fanning G; Bollekens J; Urmaliya V; Teisman A; Horton H; Jonckers THM; Raboisson P
    J Med Chem; 2017 Jul; 60(14):6137-6151. PubMed ID: 28671847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and optimization of pteridinone Toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis.
    Roethle PA; McFadden RM; Yang H; Hrvatin P; Hui H; Graupe M; Gallagher B; Chao J; Hesselgesser J; Duatschek P; Zheng J; Lu B; Tumas DB; Perry J; Halcomb RL
    J Med Chem; 2013 Sep; 56(18):7324-33. PubMed ID: 23961878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay.
    Knoepfel T; Nimsgern P; Jacquier S; Bourrel M; Vangrevelinghe E; Glatthar R; Behnke D; Alper PB; Michellys PY; Deane J; Junt T; Zipfel G; Limonta S; Hawtin S; Andre C; Boulay T; Loetscher P; Faller M; Blank J; Feifel R; Betschart C
    J Med Chem; 2020 Aug; 63(15):8276-8295. PubMed ID: 32786235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Toll-like receptor 7 agonists with novel chromeno[3,4-d]imidazol-4(1H)-one and 2-(trifluoromethyl)quinoline/ quinazoline-4-amine scaffolds.
    Dolšak A; Švajger U; Lešnik S; Konc J; Gobec S; Sova M
    Eur J Med Chem; 2019 Oct; 179():109-122. PubMed ID: 31247373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors.
    Pan T; Ding Y; Wu L; Liang L; He X; Li Q; Bai C; Zhang H
    Eur J Med Chem; 2019 Mar; 166():480-501. PubMed ID: 30739828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of tetrahydropyridopyrimidine based Toll-Like Receptor (TLR) 7/8 dual agonists.
    McGowan DC; Herschke F; Khamlichi MD; Rosauro ML; Benedicto SMP; Pauwels F; Stoops B; Pande V; Scholliers A; Van Schoubroeck B; Mostmans W; Van Dijck K; Thoné T; Horton H; Fanning G; Jonckers THM; Raboisson P
    Bioorg Med Chem Lett; 2018 Oct; 28(19):3216-3221. PubMed ID: 30143425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and optimisation of orally active TLR7 agonists for the treatment of hepatitis C virus infection.
    Tran TD; Pryde DC; Jones P; Adam FM; Benson N; Bish G; Calo F; Ciaramella G; Dixon R; Duckworth J; Fox DN; Hay DA; Hitchin J; Horscroft N; Howard M; Gardner I; Jones HM; Laxton C; Parkinson T; Parsons G; Proctor K; Smith MC; Smith N; Thomas A
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2389-93. PubMed ID: 21419626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Design of Highly Potent Toll-like Receptor 7/8 Dual Agonists for Cancer Immunotherapy.
    Wang Z; Gao Y; He L; Sun S; Xia T; Hu L; Yao L; Wang L; Li D; Shi H; Liao X
    J Med Chem; 2021 Jun; 64(11):7507-7532. PubMed ID: 34048243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.
    Hamm S; Rath S; Michel S; Baumgartner R
    J Immunotoxicol; 2009 Dec; 6(4):257-65. PubMed ID: 19848448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands.
    Zhang Z; Ohto U; Shibata T; Taoka M; Yamauchi Y; Sato R; Shukla NM; David SA; Isobe T; Miyake K; Shimizu T
    Cell Rep; 2018 Dec; 25(12):3371-3381.e5. PubMed ID: 30566863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery with polycations extends the immunostimulant Ribomunyl into a potent antiviral Toll-like receptor 7/8 agonist.
    Herberhold S; Coch C; Zillinger T; Hommertgen B; Busch N; Schuberth C; Hartmann E; Wimmenauer V; Hagmann CA; Lüdenbach B; Schlee M; Bootz F; Hartmann G; Barchet W
    Antivir Ther; 2011; 16(5):751-8. PubMed ID: 21817197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of 1-(indolin-1-yl)-2-(thiazol-2-yl)ethan-1-one derivatives as novel anti-HBV agent with potential TLR7-agonistic effect.
    Li S; Yang L; Xu Q; Li X; Zhao J; Tan Z; Gu X; Qiu J
    Eur J Med Chem; 2024 Sep; 275():116575. PubMed ID: 38865744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
    Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminopurine and aminoquinazoline scaffolds for development of potential dengue virus inhibitors.
    Venkatesham A; Saudi M; Kaptein S; Neyts J; Rozenski J; Froeyen M; Van Aerschot A
    Eur J Med Chem; 2017 Jan; 126():101-109. PubMed ID: 27750144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line.
    Das D; Sengupta I; Sarkar N; Pal A; Saha D; Bandopadhyay M; Das C; Narayan J; Singh SP; Chakrabarti S; Chakravarty R
    BMC Infect Dis; 2017 Jan; 17(1):76. PubMed ID: 28088184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.